Before exposing a woman who is, or may be, pregnant to diagnostics, a pertinent risk-benefit estimation should be made, as exposure towards ionizing radiation must be minimized. Magnetic resonance tomography (MRT) can be safely used but ultrasonography remains the imaging method of choice. Contrast agents should only be applied if the diagnosis cannot be made without their use. After 12 weeks of gestation, intrauterine exposure to iodinated contrast agents can result in disturbances of fetal thyroid function. Radioactive isotopes should be avoided if possible, especially radioactive iodine. After inadvertent exposure to radioactive isotopes, a calculation of the radiation dose should be made to estimate any risk to the embryo/fetus.

Diagnostic dyes should be used with caution. When used for marking twin pregnancies in amniocentesis, small bowel atresia as a fetotoxic effect has been described in the literature. For the diagnosis of a ruptured membrane, indigo carmine is the agent of choice, if the leak cannot be ruled out by any other method.

Diagnostic imaging

Before any examination of a pregnant woman with imaging procedures, the benefits and risks of the respective examination should be assessed.

X-ray examinations

X-rays are ionizing radiation

The energy dose is expressed in Gray (Gy). (The old dose unit was rad: 1 Gray = 100 rad.) During pregnancy the uterus dose resp. the embryo/fetus dose is relevant. The actual effective equivalent dose in the target organ (embryo) is expressed in Sievert (Sv). (The old dose designation was rem: 1 Sv = 100 rem.) For a simpler calculation of the effective organ dose a dimensionless radiation-weighting factor is used, which describes the effect of radiation on the human body. It is determined experimentally and fixed at 1, i.e. 1 Sv = 1 Gy for X-ray or γ- and β-rays, respectively. Generally, in practice milli-Sievert (1 mSv = 0.001 Sv) is used.

The dose range of usual X-ray studies

The embryo/fetus dose with usual X-ray examinations (including the lower abdomen) typically lies significantly under 50 mSv. For an individual abdominal, pelvic or lumbar spinal picture without shielding the uterus, the gonad dose is frequently even lower than 2 mSv ( ). With multiple radiograms with the uterus in the primary radiation beam, the total uterine dose must be calculated. For this purpose, it is important to know the tube voltage in kilovolts (kV), the thickness of the aluminum filter, the filter-skin distance, and the beam direction. Longer fluoroscopy times in imaging of the gastrointestinal tract or kidneys and urinary tract, could actually lead to a uterus load of 20 mSv. Table 2.20.1 provides dose values per minute for the worst case when the uterus lies in the primary radiation beam. The values vary depending the patient’s constitution (diameter) and the direction of exposure.

Table 2.20.1
Maximum value of the equivalent dose level for the uterus in mSv/min during X-ray screening with image enhancing television chain (according to the , www.dgmp.de )
Projection a.p. a.p. a.p. p.a. p.a. p.a. Lateral
Constitution thin cm normal, 22 cm thick 6 cm thin, 17 cm normal, 22 cm thick, 26 cm normal, 36 cm
Equivalent-dose 16 24 40 8 12 20 32
a.p. = anterior-posterior.
p.a. = posterior-anterior.

With computerized tomographic (CT) studies, the location of the examination is of primal importance. When the uterus is in the primary X-ray beam a uterus dose between 20 and 40 mSv – very rarely over 50 mSv – is calculated with a CT examination in modern multi-layer-spiral CT consoles. The dose is dependent upon the number of scans, the collimation, the pitch, the tube voltage, and the tube current. For a simplified estimate of the uterus dose, the volume computed tomography index (CTDI vol ), i.e. the mean radiation dose in the volume of a rotation, can be used ( ). This value is given on all modern CT consoles. Only when the CTDI vol lies significantly over 20 mGy, and the uterus is in the primary X-ray beam, should a specialized center be consulted for a detailed individual estimate of the uterus dose through patient- and equipment-specific data. The scattered radiation from examinations of other body regions, such as the upper abdomen, thorax, extremities or head, can be ignored because it is generally below 1 mSv. Nevertheless, attention should always be paid to using a lead apron to protect against scattered radiation because this further reduces the total dose ( ). Modern CT consoles have several mechanisms that reduce patient dose without sacrificing diagnostic power, e.g. dose modulation protocols. In contrast to the American Thoracic Society, which recommends lung scintigraphy for pregnant women with suspected pulmonary embolism (PE) and normal chest X-rays ( ), other experts recommend CT pulmonary angiography as first line diagnostic imaging modality before scintigraphy ( ). During CT of the chest, the fetus is outside the primary X-ray beam and receives only indirect, scattered irradiation. Iodinated contrast agents should only be used if clearly indicated because of the added risk of fetal hypothyroidism (compare Section 2.20.2 ) and the exposure to ionizing radiation should be kept as low as possible.

Effects of radiation

With X-rays – as with other ionizing rays – two categories of biological radiation effects are distinguished: deterministic and stochastic effects. Deterministic effects only appear above a certain threshold dose and lead to a reduction or a complete loss of organ or tissue function due to cellular death ( ). Teratogenic effects belong to these deterministic effects. Depending on the dose and the embryonic developmental stage, this may result in the death of the embryo, or malformation of various organ systems, specifically the eyes, general growth retardation, microcephaly and mental retardation. This has been documented both in animal experiments as well as empirically in humans ( ). During the first 5 days after conception (i.e., during the “all-or-nothing phase”) the lowest lethal dose is calculated at 100 mGy. During actual embryogenesis, this value is estimated at 250–500 mGy, then later at >1 Gy ( ). Severe CNS malformations during the early embryogenesis period (18–36 days after conception) are only to be expected beginning at 200 mGy. Permanent growth retardation can be expected at 250–500 mGy. Microcephaly and mental retardation is observed, above all, after doses >200 mGy between gestational weeks 10 and 17.

With a radiation dose of <50 mGy most studies conclude that no substantially increased malformation risk in humans is expected ( ). One study observed a lower birth weight after dental X-rays during pregnancy. The authors speculated that impairment of maternal thyroid function by X-rays was responsible for these findings ( ). Other authors discuss the underlying dental illness as causal ( ).

Much more difficult than estimating the teratogenic X-ray risk is assessing the stochastic mutagenic and carcinogenic effects, because there is no threshold dose under which no effect would be expected. Damage of a single cell can lead to an illness which, with higher exposure may result in a greater incidence of, for example, leukemia following prenatal X-ray exposure ( ). Point mutations might also occur spontaneously. The radiation dose leading to a doubling of the point mutation rate is given as 1.2 Gy ( ). A doubling of the mutation rate of a certain gene does not necessarily mean a doubling of the associated frequency of the disease. On the other hand, the completely inadequate knowledge of the effects on later generations must lead to greater caution in the definition of safe exposure values for the population at large ( ).

Empirical evidence on the risk for stochastic X-ray effects in the literature is still inconsistent. Among the parents of some 500 children with neuroblastomas, the use of X-ray examinations before pregnancy was no more frequent than that in a healthy control group ( ). In a case control study no significant association between a history of radiography in pregnancy and a risk of childhood leukemia was found ( ). A study of twin pregnancies reported a 2.4 factor increase in the risk of leukemia with a fetal dose of 0.01 Sv or more ( ). already considers an increased leukemia risk when additional prenatal X-ray exposure of the embryo lies in the range of the natural background radiation of about 0.001 Sv/year. By contrast, other authors assume there is no risk for the embryo with exposure of 0.02–0.05 Sv ( ). In a case control study from the USA, an increased risk for rhabdomyosarcoma was found in the children of mothers who had had an X-ray examination during pregnancy ( ). However, due to methodological irregularities, these results should be interpreted with necessary caution.

calculated the relative and absolute risk for children under the age of 15 years to become affected by a cancer after intrauterine X-ray exposure. They gave the absolute risk as 8% per Gray. Their detailed calculation was based on the largest world-wide data collection on the risk of cancer through intrauterine X-ray exposure, primarily pelvimetry, in the Oxford Survey of Childhood Cancers ( ). The authors derive comparable risk coefficients from the Japanese data on the atomic bomb victims and conclude that there is also an increased risk from a comparatively low fetal dose of 10 mSv, which, in the 1950s, was reached during a pelvic X-ray. Other authors consider such an assumption of risk to be too high and suggest that the risk of an exposure lower than 100 mSv is negligible compared to the background risk for cancer ( ). They also point to the group of intrauterine-exposed Hiroshima victims comprising not even 1,000 survivors, and to the data of the experience of exposed children in Hiroshima. However, these studies, frequently cited as proof for a rather low risk of cancer after radioactive exposure, should be critically evaluated in the light of the methodological shortcomings and the political interests of the American researchers at that time.

Ultrasound

For about 30 years, ultrasound has been used during all phases of pregnancy. Numerous animal experiments (overview in ) and epidemiological studies (overview in ) have analyzed the effects on the fetus. Negative effects could be caused mainly by local hyperthermia. Although anomalies such as an increase in fetal activity, reduced birth weight, delayed speech development and increased left-handedness, have been mentioned by individual researchers ( ) as consequences of ultrasound examinations, these effects cannot be confirmed ( ). Follow-up studies on considerably more than 1,000 children between the ages of 1–8 years, whose mothers had received ultrasound examinations between the eighteenth and thirty-eighth week, showed no differences related to weight gain and other developmental parameters between children whose mothers were examined by ultrasound five times and those whose mothers had only one ultrasound examination ( ). Pulsed doppler studies, flow measurements, and studies in the first trimester require a higher dose of energy and, theoretically, can damage embryonic tissue by warming. Thermal or non-thermal damage of the fetus cannot be ruled out, especially with the modern high output devices, and is theoretically conceivable ( ). The sees the available data as insufficient for proving a causal relationship between medically indicated ultrasound examinations and damaging effects on the fetus. Using ultrasound only when medically indicated, as well as adhering to the ALARA principle (as low as reasonably achievable), is recommended for obstetrical ultrasound.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here